Actis invests in specialist medical equipment manufacturing co

By Admin
The pan-emerging markets private equity company Actis has made a significant majority investment in Nanjing Micro-Tech. Micro-Tech is a manufacturer of...

The pan-emerging markets private equity company Actis has made a significant majority investment in Nanjing Micro-Tech. Micro-Tech is a manufacturer of specialist medical equipment to both Chinese and international hospitals and surgeries.

This investment builds on Actis’s strong track record of healthcare investments in India. The company Nanjing Micro-Tech was founded in 2000 and has grown to become the largest local player in the Chinese endoscopy consumable sector.

It also has a leading market position in non-vascular stents and disposable biopsy forceps in China. Nanjing Micro-Tech has an extensive distribution network with approximately 120 distributors and particular strength in Jiangsu, Shanghai, Zhejiang, and Shadong.

The diagnosis and treatment that its products facilitate can dramatically improve patient prognosis. The global endoscopy consumable sector was a US$4.4 billion market in 2011 and is expected to reach US$7.6 billion in 2017 with 9.4%  CAGR.

Meng Ann Lim, Head of China and South East Asia at Actis said, “Nanjing Micro-Tech is the number one domestic player in the Chinese endoscopy consumable market, it has built up a loyal following of doctors thanks to the consistently high quality of its products, the reach of its distribution base and its record of innovation.” 

Mr. Lim also said, “We see great potential in the Chinese healthcare sector and look forward to working with CEO Mr. Leng and his team, with whom we share a clear vision of the future for Nanjing Micro-Tech.”  “Nanjing Micro-Tech has grown steadily over the last 12 years. We are very proud of the reputation we have built and the faith doctors and patients place in our products. Our partnership with Actis will take us to the next stage, equipping us with a clearer strategy, a world-class management team, and new routes of business expansion.”

Actis invests in the emerging markets with a growing portfolio of investments in Asia, Africa and Latin America. The company identifies investment opportunities in private equity, energy and realty. 

Share
Share

Featured Articles

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare